195 related articles for article (PubMed ID: 16284608)
21. Outcome of hematopoietic stem cell transplantation of children with very high risk acute lymphoblastic leukemia in first complete remission.
Schechter T; Ishaqi KM; Rojas M; Irina Z; Doyle JJ; Gassas A
Pediatr Transplant; 2010 May; 14(3):377-82. PubMed ID: 19793223
[TBL] [Abstract][Full Text] [Related]
22. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976
[TBL] [Abstract][Full Text] [Related]
23. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
Ribera JM; Ortega JJ; Oriol A; Bastida P; Calvo C; Pérez-Hurtado JM; González-Valentín ME; Martín-Reina V; Molinés A; Ortega-Rivas F; Moreno MJ; Rivas C; Egurbide I; Heras I; Poderós C; Martínez-Revuelta E; Guinea JM; del Potro E; Deben G
J Clin Oncol; 2007 Jan; 25(1):16-24. PubMed ID: 17194902
[TBL] [Abstract][Full Text] [Related]
24. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ;
Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
[TBL] [Abstract][Full Text] [Related]
25. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors.
Kobayashi K; Kami M; Murashige N; Kusumi E; Kishi Y; Hamaki T; Hori A; Matsumura T; Yuji K; Masuo S; Mori S; Miyakoshi S; Tanosaki R; Mitamura T; Takaue Y; Taniguchi S;
Br J Haematol; 2005 Jun; 129(6):795-802. PubMed ID: 15953007
[TBL] [Abstract][Full Text] [Related]
27. Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients.
Hamaki T; Kami M; Kanda Y; Yuji K; Inamoto Y; Kishi Y; Nakai K; Nakayama I; Murashige N; Abe Y; Ueda Y; Hino M; Inoue T; Ago H; Hidaka M; Hayashi T; Yamane T; Uoshima N; Miyakoshi S; Taniguchi S
Bone Marrow Transplant; 2005 Mar; 35(6):549-56. PubMed ID: 15756282
[TBL] [Abstract][Full Text] [Related]
28. Isolated HLA-C mismatches in unrelated donor transplantation for CML.
Tiercy JM; Passweg J; van Biezen A; Zander A; Kröger N; Gratwohl A; Chapuis B; Helg C; Brinch L; Cornelissen J; Oudshoorn M; Ruutu T; Volin L; Niederwieser D; Roosnek E;
Bone Marrow Transplant; 2004 Aug; 34(3):249-55. PubMed ID: 15195077
[TBL] [Abstract][Full Text] [Related]
29. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
[TBL] [Abstract][Full Text] [Related]
30. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
De Souza CA; Vigorito AC; Ruiz MA; Nucci M; Dulley FL; Funcke V; Tabak D; Azevedo AM; Byington R; Macedo MC; Saboya R; Penteado Aranha FJ; Oliveira GB; Zulli R; Martins Miranda EC; Azevedo WM; Lodi FM; Voltarelli JC; Simões BP; Colturato V; De Souza MP; Silla L; Bittencourt H; Piron-Ruiz L; Maiolino A; Gratwohl A; Pasquini R
Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
32. Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Mohty M; Labopin M; Tabrizzi R; Theorin N; Fauser AA; Rambaldi A; Maertens J; Slavin S; Majolino I; Nagler A; Blaise D; Rocha V; ;
Haematologica; 2008 Feb; 93(2):303-6. PubMed ID: 18245655
[TBL] [Abstract][Full Text] [Related]
33. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
[TBL] [Abstract][Full Text] [Related]
34. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI.
Willemze AJ; Geskus RB; Noordijk EM; Kal HB; Egeler RM; Vossen JM
Bone Marrow Transplant; 2007 Aug; 40(4):319-27. PubMed ID: 17572715
[TBL] [Abstract][Full Text] [Related]
35. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
38. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
[TBL] [Abstract][Full Text] [Related]
39. Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.
Solomon SR; Savani BN; Childs R; Montero A; Boss C; Read EJ; Leitman SF; Barrett AJ
Biol Blood Marrow Transplant; 2005 Aug; 11(8):619-26. PubMed ID: 16041312
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukemia in third remission.
Afify Z; Hunt L; Green A; Guttridge M; Cornish J; Oakhill A
Bone Marrow Transplant; 2005 Jun; 35(11):1041-7. PubMed ID: 15806120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]